SA PRO
Free Account
LBRXLBRX
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
1 analyst·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 48% higher.

Bear Case
$31.00
+37%
Consensus
$33.33
+48%
Bull Case
$35.00
+55%
Price Range1 analyst
Low
Consensus
High
$31.00
$35.00
Current Target
Current Price
$22.58
Upside to Target
$10.75

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 9, 2026Roth Capital
LB Pharmaceuticals initiated with a Buy at Roth Capital
Target:$31.00
+49.0%from $20.80
Dec 11, 2025Stifel Nicolaus
LB Pharmaceuticals price target raised to $35 from $27 at Stifel
Target:$35.00
+63.9%from $21.36
Oct 6, 2025Leerink Partners
LB Pharmaceuticals initiated with an Outperform at Leerink
Target:$34.00
+125.9%from $15.05
Oct 6, 2025Stifel Nicolaus
LB Pharmaceuticals initiated with a Buy at Stifel
Target:$27.00
+79.4%from $15.05

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance